¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå º¸°í¼­ : Á¦Ç°, ¿ëµµ, Áö¿ªº°(2025-2033³â)
Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2025-2033
»óǰÄÚµå : 1820236
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 144 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,313,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,751,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,190,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â 2,217¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 3,391¾ï ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2033³â±îÁö 4.8%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¸é¿ªÁ¶ÀýÁ¦´Â °¨¿°, ¸é¿ª°áÇÌ ¹× Ç×ü Àü´ÞÀÇ º¯È­¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀ» ¼öÁ¤Çϴµ¥ »ç¿ëµÇ´Â ¾à¹° ±×·ìÀÔ´Ï´Ù. ÀÌµé ¾àÁ¦´Â ÀϹÝÀûÀ¸·Î ´ÜÀÏŬ·ÐÇ×ü, »çÀÌÅäÄ«ÀÎ, ·¹¹Ù¹Ì¼Ö, Ä®¸ÞÆ®°Ô·À±Õ(BCG) µîÀ» Æ÷ÇÔÇÕ´Ï´Ù. À̵éÀº ¾Ï, õ½Ä, Á¾¾ç, À¯Àü¼º Ç÷°ü¼º ºÎÁ¾, ¼öÆ÷â, ³¶Ã¢, ¾Ë·¹¸£±â, ·ù¸¶Æ¼½º °üÀý¿° µîÀÇÀÚ°¡ ¸é¿ª ÁúȯÀÇ Ä¡·á¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ÇöÀç, ¿°Áõ¼º ÀåÁúȯ(IBD)À» °ü¸®Çϱâ À§ÇØ, ¸é¿ªÁ¶ÀýÁ¦¸¦ »ý¹°ÇÐÀû Á¦Á¦¿Í °°Àº ´Ù¸¥ ¾àÁ¦¿Í º´¿ëÇÏ´Â °ÍÀ» ±ÇÀåÇÏ´Â ÀÇ·á Á¾»çÀÚµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå µ¿Çâ :

±Þ¼ÓÇÑ µµ½ÃÈ­, ¼Òµæ ¼öÁØ »ó½Â, °¡°ø ½Äǰ ¼Òºñ·® Áõ°¡ µîÀ» ¹è°æÀ¸·Î ÇÑ °³ÀÎÀÇ °Ç°­¿¡ ÇØ·Î¿î ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÌ ¼¼°èÀûÀÎ ¸¸¼º ÁúȯÀÇ À¯º´·üÀÇ ´ëÆøÀûÀÎ »ó½ÂÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. À̰ÍÀº Àå±â À̽ÄÀÇ Çʿ伺À» ´õ¿í Çâ»ó½Ã۰í, Àå±â À̽ÄÀ» ¹ÞÀº ȯÀÚ¿¡¼­ À¯¸ÁÇÑ Ä¡·áÁ¦·Î¼­ ±¹¼Ò ¸é¿ª Á¶ÀýÁ¦ ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ Áõ°¡¿Í »ç°í Áõ°¡´Â Àå±â ºÎÀüÀÇ À§ÇèÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±× °á°ú Àå±âÁ¦°øÀ» Àå·ÁÇÏ´Â ÇàÁ¤´ç±¹°ú ºñÁ¤Ä¡´ç±¹ÀÇ ¿òÁ÷ÀÓÀÌ È°¹ßÇØÁö°í, ¼¼°èÀûÀ¸·Î ¸é¿ªÁ¶ÀýÁ¦ ¿Ü¿ë¾àÀÇ ¸ÅÃâÀ» ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î IBD¿Í ÀÚ°¡¸é¿ªÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¸é¿ªÁ¶ÀýÁ¦´Â ¶ÇÇÑ ½ºÅ×·ÎÀ̵åÀÇ Àå±âÀûÀÎ Çʿ伺À» ÁÙÀ̰í, À翬ÀÇ Àç¹ßÀ» ¿¹¹æÇϰí, Ç×»ýÁ¦°¡ È¿°ú°¡ ¾ø´Â ÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ º´¿ë ¿ä¹ý¿¡ ÀÌ¿ëµË´Ï´Ù. ¶ÇÇÑ, Fluvoxamine, Tocilizumab, Baricitinib ¹× Remdesivir¸¦ Æ÷ÇÔÇÑ ÀϺΠ¸é¿ªÁ¶ÀýÁ¦´Â Äڷγª¹ÙÀÌ·¯½º Áúȯ(COVID-19) ÀÔ¿ø ȯÀÚÀÇ Ä¡·á¿¡ Àû¿ëµË´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀϺΠÈĺ¸ Á¦Ç°Àº ÇöÀç Èıâ ÀÓ»ó½ÃÇè ´Ü°è¿¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°ÀÇ °³¹ßÀº ¸é¿ªÁ¶ÀýÁ¦°¡ »ý¸íÀ» À§ÇùÇÏ´Â ´Ù¾çÇÑ Áúº´ÀÇ Ä¡·á¿¡ ´ëÇÑ ÀÀ¿ëÀ» È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå SWOT ºÐ¼®

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global immunomodulators market size reached USD 221.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 339.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033.

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

Breakup by Product:

Breakup by Application:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Immunomodulators Market

6 Market Breakup by Product

7 Market Breakup by Application

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â